FibroBiologics, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has FibroBiologics, Inc. Common Stock's balance sheet done over the years? Its assets were worth $11,821,000 last year. 89% of FibroBiologics, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $10,568,000.
Debt to Assets
| 2023 | 11821000 | 10.56M | 89.4% |
|---|
FBLG Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 9.16M |
Short term investments | 0 |
Net receivables | 0 |
Inventory | 0 |
Other current assets | 52K |
Total current assets | 9.21M |
Non-current assets: | |
Property, Plant and Equipment | 2.60M |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 0 |
Total non-current assets | 2.60M |
Total assets | 11.82M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 362K |
Total current liabilities | 9.18M |
| Non-current liabilities: | |
Long term debt | 1.38M |
Deferred tax | 0 |
Other non-current liabilities | 0 |
Total non-current liabilities | 1.38M |
Total liabilities | 10.56M |